Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 4.005 USD 1.39%
Market Cap: 183.6m USD
Have any thoughts about
Repro Med Systems Inc?
Write Note

Repro Med Systems Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repro Med Systems Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Repro Med Systems Inc
NASDAQ:KRMD
Free Cash Flow
-$5.7m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Free Cash Flow
$3.1B
CAGR 3-Years
-4%
CAGR 5-Years
5%
CAGR 10-Years
11%
Boston Scientific Corp
NYSE:BSX
Free Cash Flow
$2.2B
CAGR 3-Years
12%
CAGR 5-Years
28%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Free Cash Flow
$3.2B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Free Cash Flow
$6.5B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Free Cash Flow
$586m
CAGR 3-Years
-32%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
No Stocks Found

Repro Med Systems Inc
Glance View

Market Cap
182.9m USD
Industry
Health Care

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

KRMD Intrinsic Value
3.136 USD
Overvaluation 22%
Intrinsic Value
Price

See Also

What is Repro Med Systems Inc's Free Cash Flow?
Free Cash Flow
-5.7m USD

Based on the financial report for Dec 31, 2023, Repro Med Systems Inc's Free Cash Flow amounts to -5.7m USD.

What is Repro Med Systems Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-47%

Over the last year, the Free Cash Flow growth was 30%. The average annual Free Cash Flow growth rates for Repro Med Systems Inc have been -47% over the past three years .

Back to Top